Little House Capital LLC Novartis Ag Transaction History

Little House Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$80.93 - $91.1 $674,389 - $759,136	-8,333 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $49,256 - $69,009	697 Added 9.13%	8,333 $687,000
Q4 2019 Feb 12, 2020	SELL	$84.35 - $95.37 $4,639 - $5,245	-55 Reduced 0.72%	7,636 $723,000
Q3 2019 Nov 05, 2019	SELL	$85.54 - $94.26 $9,837 - $10,839	-115 Reduced 1.47%	7,691 $668,000
Q2 2019 Aug 15, 2019	BUY	$75.4 - $92.8 $588,572 - $724,396	7,806 New	7,806 $731,000
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $574,925 - $707,600	-7,625 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$75.32 - $86.15 $149,208 - $170,663	1,981 Added 35.1%	7,625 $733,000
Q4 2018 Feb 13, 2019	BUY	$73.66 - $82.02 $415,737 - $462,920	5,644 New	5,644 $484,000

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Little House Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Little House Capital LLC with notifications on news.